INS and Insulin resistance: Surgeons learned, over the years, that type 2 diabetes is a complex heterogeneous disease mainly driven by insulin resistance with a genetic predisposition, inevitably progressive despite glucose-lowering treatment, with 50% of individuals requiring insulin therapy within 10 years [77].